1 hour CME/CE program provided by the AAFP (Amer Academy of Family Physicians) and PCNA

COURSE OVERVIEW:

This case-based presentation is designed to provide participants with evidence-based content and best practices to effectively increase the awareness of novel approaches to reduce LDL cholesterol in statin-intolerant patients and those patients at high cardiovascular risk. The educational content will also address patient/clinician communication and shared decision-making as outlined below. The multidisciplinary faculty was assembled to demonstrate the respective strengths of medicine and nursing in managing these challenging patients. 

AUDIENCE:
Nurses, advanced practice nurses, and other healthcare providers interested in the prevention and management of cardiovascular disease.

NOTE TO OUR PHYSICIAN COLLEAGUES:

Credit for physician audience is provided through our collaborating partner, the American Academy of Family Physicians (AAFP). Please follow this link for access to the activity and CME credit information.

www.aafp.org/lipid/management

COST:
This online educational activity is offered free of charge.

PARTICIPATION IN THE ACTIVITY AND RECEIPT OF CERTIFICATE OF CREDIT:

• Complete the pretest.
• View the videotaped presentation
• Complete the post-test (you can take the post-test more than once if needed to achieve a passing score of 75%).
• Complete the online evaluation form at the end of the activity
• Print your CE certificate.

ACCREDITOR:

This educational activity is provided by the Preventive Cardiovascular Nurses Association (PCNA). PCNA is accredited by the American Association of Nurse Practitioners (AANP) as an approved provider of Nurse Practitioner continuing education, provider number 030602. 

GRANTOR:

This activity is being presented by The Preventive Cardiovascular Nurses Association (PCNA) in collaboration with the American Academy of Family Practice (AAFP). Partial funding was provided by an unrestricted educational grant from Pfizer, Inc. 

Reviewed Date: January 2017

Describe the biochemical basis of abnormal lipid metabolism, noting areas that are targeted in both current and potential future therapies.
Describe an evidence-based therapeutic approach to the patient with a true intolerance to statin therapy.
Outline a treatment plan for the patient who has an inadequate response to high intensity statin therapy, including strategies to rule out suboptimal adherence and optimization of patient education.
Describe the integration of shared decision-making into the clinical encounter for a patient with elevated LDL-cholesterol.